Denali Therapeutics Inc. - DNLI

About Gravity Analytica
Recent News
- 03.10.2025 - March 10, 2025 1:40 PM PDT - March 4, 2025 2:10 PM PST : Leerink Partners Global Healthcare Conference
- 03.10.2025 - March 10, 2025 1:40 PM PDT - March 4, 2025 2:10 PM PST : Leerink Partners Global Healthcare Conference
- 03.04.2025 - March 4, 2025 3:10 PM PST - March 4, 2025 3:40 PM PST : TD Cowen 45th Annual Health Care Conference
- 03.04.2025 - March 4, 2025 3:10 PM PST - March 4, 2025 3:40 PM PST : TD Cowen 45th Annual Health Care Conference
- 02.27.2025 - Denali Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
- 02.27.2025 - Denali Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
- 02.27.2025 - Denali Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
- 02.11.2025 - February 11, 2025 9:00 AM PST - February 11, 2025 9:30 AM PST : Oppenheimer 35th Annual Healthcare Life Sciences Conference
- 02.11.2025 - February 11, 2025 9:00 AM PST - February 11, 2025 9:30 AM PST : Oppenheimer 35th Annual Healthcare Life Sciences Conference
- 02.06.2025 - Denali Therapeutics Announces Primary Analysis and Long-Term Follow-Up of Phase 1/2 Study in Hunter Syndrome (MPS II) with Tividenofusp Alfa
Recent Filings
- 02.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
- 02.27.2025 - S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
- 02.27.2025 - EX-99.1 EX-99.1
- 02.27.2025 - 8-K Current report
- 02.27.2025 - S-8 Securities to be offered to employees in employee benefit plans
- 02.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors